Skip to content
2000
Volume 16, Issue 4
  • ISSN: 1570-1611
  • E-ISSN: 1875-6212

Abstract

Inodilators are a heterogeneous group of drugs with vasodilatory and inotropic effects. The cardioprotective effect of levosimendan is multifactorial, but now research on levosimendan is focused on the organ-protective properties of this drug in different settings, the regimen that seems to provide the greatest cardiologic and systemic benefits is early administration of levosimendan. We try to answer four questions in this review, which type of patients need this drug? what is the best time to start with it? and the best way that we could give it and finally the reasons for use it.

Loading

Article metrics loading...

/content/journals/cvp/10.2174/1570161115666171116150434
2018-07-01
2025-09-19
Loading full text...

Full text loading...

/content/journals/cvp/10.2174/1570161115666171116150434
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test